Search clinical trials for: Paracetamol slow dissolution suspension

Total 31 results

GlaxoSmithKline

Completed

A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions

Healthy Subjects

United States
AstraZeneca

Completed

Study to Investigate Relative Bioavailability of up to Five Different Formulations of AZD5069

Uncontrolled and Persistent Asthma

United Kingdom
HALEON

Completed

A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects

Pain

Czechia
reMYND

Recruiting

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Alzheimer Disease

Netherlands, Spain
Santen Inc.

Completed

Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease

Dry Eye

United States
The Second Hospital of Nanjing Medical University

Recruiting

Washed Microbiota Transplantation for Chronic Constipation in Adults

Constipation

China
Mette Cathrine Oerngreen
Elsass Foundation

Recruiting

Paracetamol Study in Patients With Low Muscle Mass

Cerebral Palsy | SMA II

Denmark
Sanofi

Completed

Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.

Pain | Fever

France
Pfizer

Completed

A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects

Healthy

Belgium
AstraZeneca

Withdrawn

A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects

Healthy Male Subjects | Pharmacokinetics | Safety | Food Effect

United Kingdom
Sun Yat-sen University

Recruiting

KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial (KDR-NVG)

Neovascular Glaucoma | Neovascularization

China
Stanford University

Completed

Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol

Type 1 Diabetes

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Paracetamol

Obesity, Morbid

Norway
Boehringer Ingelheim

Completed

Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers

Healthy
Alcon Research

Completed

Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Open-Angle Glaucoma
Boehringer Ingelheim

Completed

Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients

Migraine Disorders
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

A Study of 2 Doses of MAP0010 in Adult Asthmatics (P202)

Asthma

United States
Daiichi Sankyo, Inc.

Completed

Colesevelam for Children With Type 2 Diabetes (WELKid DM)

Type 2 Diabetes Mellitus

United States
University of Colorado, Denver

Recruiting

Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Hearing Loss | Smith-Lemli-Opitz Syndrome | Cone-Rod Dystrophy

United States
Alcon Research

Completed

Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®

Ocular Hypertension | Open Angle Glaucoma
Boehringer Ingelheim

Completed

Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects

Healthy
Nanfang Hospital of Southern Medical University
Shen-Zhen City Maternity and Child Healthcare Hospital; Guangzhou Panyu Central... and other collaborators

Completed

Multi-Center Study of Different Doses Domperidone in Feeding Intolerance (MCSDDDFI)

Premature Birth | Feeding Intolerance | Gastric Retention | Domperidone Overdose

China
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan; Q-Pharm Pty...

Completed

Safety and Blood Level Study of Unit Dose Budesonide (UDB P101)

Asthma

Australia
Bond Avillion 2 Development LP

Completed

To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years. (BLANC)

Asthma

United States
Centre de Maternité de Monastir

Completed

Comparison of Two Routes of Administration of a Multimodal Analgesic Protocol in Postoperative Cesarean Section

Postoperative Pain | Cesarean Section; Complications, Wound, Infection (Following Delivery) | Spinal Anaesthesia During the Puerperium

Tunisia
University of California, Los Angeles
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Terminated

A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine

Fungal Keratitis
Eli Lilly and Company

Completed

Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

Diabetes Mellitus, Type 2

Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
Dr. Falk Pharma GmbH

Completed

Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis

Eosinophilic Esophagitis

Germany
AFT Pharmaceuticals, Ltd.

Withdrawn

Maxi-Analgesic Phase 2 Study to Compare the Analgesic Effects in Different Dosing Groups to Treat Teeth Extraction Pain

Dental Pain

United States
Novacea
Schering-Plough

Suspended

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Leukemia

United States, Australia, Canada

3

Subscribe